KABIKINASE - PWS 1500000UNITS/VIAL
KABIKINASE - PWS 1500000UNITS/VIAL
Discontinued
DIN Number
02126141
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
pharmacia & upjohn inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02126141
AIG Number0107605002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B01AD01 STREPTOKINASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
,
Intracoronary
AHFS Classification20:12.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
STREPTOKINASEActive
Strength: 1500000 UNIT / VIAL
Monograph: STREPTOKINASE